Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

India

CDSCO permission, DPCO pricing and separate public, CGHS and private arrangements shape access. A product-specific route still requires current local evidence.

CDSCO
Government / NPPA
HTAIn / requesting government department
Indian schemes / state authorities / providers
4 decision nodes18 cited sources

For education only โ€” not regulatory, pricing or legal advice.

About the content and how to use it